tiprankstipranks
Trending News
More News >
Neumora Therapeutics, Inc. (NMRA)
NASDAQ:NMRA
US Market

Neumora Therapeutics, Inc. (NMRA) Income Statement

Compare
351 Followers

Neumora Therapeutics, Inc. Income Statement

Last quarter (Q3 2025), Neumora Therapeutics, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Neumora Therapeutics, Inc.'s net income was $-56.76M. See Neumora Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -668.00K$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 263.46M$ 187.53M$ 135.87M$ 237.32M$ 95.52M
Depreciation and Amortization
$ 631.00K$ 668.00K$ 594.00K$ 538.00K$ 105.00K
EBITDA
$ -262.83M$ -187.53M$ -135.28M$ -236.78M$ -95.41M
Operating Income
$ -263.46M$ -188.19M$ -135.87M$ -237.32M$ -95.52M
Other Income/Expenses
$ 19.86M$ -47.46M$ 4.97M$ 11.00K$ -3.75M
Pretax Income
$ -243.61M$ -235.66M$ -130.90M$ -237.31M$ -99.27M
Net Income
$ -243.79M$ -235.93M$ -130.90M$ -237.31M$ -99.27M
Per Share Metrics
Basic EPS
$ -1.53$ -1.49$ -0.86$ -1.56$ -0.65
Diluted EPS
$ -1.53$ -1.49$ -0.86$ -1.56$ -0.65
Weighted Average Shares Outstanding
159.38M 158.83M 151.95M 151.95M 151.95M
Weighted Average Shares Outstanding (Diluted)
159.38M 158.83M 151.95M 151.95M 151.95M
Currency in USD

Neumora Therapeutics, Inc. Earnings and Revenue History